InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-15.7%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
无可用的信号评分。
Browse the complete record of transactions filed by Savacool Kristi A, Directeur Médical. Officer active across 1 company, notably TrueBlue, Inc.. Cumulatively, 6 reports have been recorded. Split: 1 buy · 0 sell. Total volume traded: €47k. History available since 4 February 2022. The latest transaction was filed on 20 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Savacool Kristi A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
27,566 股0Common StockSEC:0001332706-26-000002:0
18,111 股0Common StockSEC:0000768899-25-000059:0
10,050 股0Common StockSEC:0000768899-24-000045:0
4,550 股@ US$10.98100.0% 占其流量Common StockSEC:0000768899-23-000134:0
标准退出：2024年1月24日 (T+90)
7,116 股0Common StockSEC:0000768899-23-000024:0
4,956 股0Common StockSEC:0000768899-22-000033:0
6 条申报中的 6 条
About Savacool Kristi A
Savacool Kristi A is Directrice Médical and a director of TrueBlue, Inc. She has 6 filings in total, and across the 6 sampled recent filings, buys amount to EUR 47290 and sells to EUR 0, with a date range from 2022-02-08 to 2026-02-24. The modal transaction nature is Attribution.
